Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Numan A. AlAbdan"'
Autor:
Numan A. AlAbdan, Omar A. Almohammed, Maryam S. Altukhaim, Mahfooz A. Farooqui, Mubarak I. Abdalla, Hazza Q. Al Otaibi, Norah R. Alshuraym, Shahad N. Alghusun, Lama H. Alotaibi, Abdullah A. Alsayyari
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background During the month of Ramadan, Muslims abstain from daytime consumption of fluids and foods, although some high-risk individuals are exempt. Because fasting's effects on the risk of acute kidney injury (AKI) have not been establishe
Externí odkaz:
https://doaj.org/article/1ffc637a9ccf41fea91f740b4fc2215d
Autor:
Numan A, Alabdan, Abdulla A, Al-Sayyari, Fayez F, AlHejaili, Yousif A, Alrajhi, Shazia M, Adnan, Asrar S, Aldelhm, Rayan M, Hakami, Senthilvel, Vasudevan
Publikováno v:
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 32(5)
One of the tools used to measure the quality of life in hemodialysis (HD) patients is the Kidney Disease Quality of Life (KDQOL) survey. The KDQOL has been through several developmental processes, with the most recent one being the KDQOL-36™. Our s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7116490086701524dbf8f5529c31d82a
https://pubmed.ncbi.nlm.nih.gov/35532706
https://pubmed.ncbi.nlm.nih.gov/35532706
Autor:
Timothy H. Self, Elizabeth A. Tolley, Sami A. Sakaan, Carolyn D. Cummings, Joanna Q. Hudson, Numan Abdulraman Alabdan, Carrie S. Oliphant
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 34:695-702
tudy Objectives The effect of chronic kidney disease (CKD) on warfarin has gained attention because of an increased risk of thromboembolism and an increased risk of bleeding associated with warfarin treatment in these patients. Data suggest that pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa5fe0e9a8f6442d9b47389b7191619
https://doi.org/10.1002/phar.1445
https://doi.org/10.1002/phar.1445
Autor:
Numan Abdulraman Alabdan, Timothy H. Self, Jessica L. Wallace, Anne B. Reaves, Carrie S. Oliphant, Lydia Hutchison, Christopher W. Sands, Elizabeth A. Tolley
Publikováno v:
Journal of thrombosis and thrombolysis. 36(1)
Achieving therapeutic anticoagulation with warfarin is complicated by substantial inter-patient and intra-patient variability with numerous factors known to influence dose requirements. Obesity is one factor for which there remains no study to date i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a66700c46c69197a45f83e975c412840
https://pubmed.ncbi.nlm.nih.gov/23015280
https://pubmed.ncbi.nlm.nih.gov/23015280
Autor:
Numan A Alabdan, Abdulla A Al-Sayyari, Fayez F AlHejaili, Yousif A Alrajhi, Shazia M Adnan, Asrar S Aldelhm, Rayan M Hakami, Senthilvel Vasudevan
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 32, Iss 5, Pp 1365-1373 (2021)
One of the tools used to measure the quality of life in hemodialysis (HD) patients is the Kidney Disease Quality of Life (KDQOL) survey. The KDQOL has been through several developmental processes, with the most recent one being the KDQOL-36™. Our s
Externí odkaz:
https://doaj.org/article/d99d3e7e812047aca485f208633ad217